Research Papers:
Tristetraprolin inhibits mitochondrial function through suppression of α-Synuclein expression in cancer cells
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1969 views | HTML 3963 views | ?
Abstract
Mai-Tram Vo1, Seong Hee Choi1, Ji-Heon Lee2, Chung Hwan Hong1, Jong Soo Kim2, Unn Hwa Lee1, Hyung-Min Chung2, Byung Ju Lee1, Jeong Woo Park1 and Wha Ja Cho1
1Department of Biological Sciences, University of Ulsan, Ulsan, 680-749, Korea
2Department of Stem Cell Biology, School of Medicine, Konkuk University, Gwangjin-Gu, Seoul, 143-701, Korea
Correspondence to:
Jeong Woo Park, email: [email protected]
Wha Ja Cho, email: [email protected]
Keywords: tristetraprolin, mitochondrial dynamics, α-Synuclein
Received: December 14, 2016 Accepted: March 19, 2017 Published: March 30, 2017
ABSTRACT
Mitochondrial dynamics play critical roles in maintaining mitochondrial functions. Here, we report a novel mechanism for regulation of mitochondrial dynamics mediated by tristetraprolin (TTP), an AU-rich element (ARE)-binding protein. Overexpression of TTP resulted in elongated mitochondria, down-regulation of mitochondrial oxidative phosphorylation, reduced membrane potential, cytochrome c release, and increased apoptotic cell death in cancer cells. TTP overexpression inhibited the expression of α-Synuclein (α-Syn). TTP bound to the ARE within the mRNA 3'-untranslated regions (3′-UTRs) of α-Syn and enhanced the decay of α-Syn mRNA. Overexpression of α-Syn without the 3′-UTR restored TTP-induced defects in mitochondrial morphology, mitochondrial oxidative phosphorylation, membrane potential, and apoptotic cell death. Taken together, our data demonstrate that TTP acts as a regulator of mitochondrial dynamics through enhancing degradation of α-Syn mRNA in cancer cells. This finding will increase understanding of the molecular basis of mitochondrial dynamics.
![Creative Commons License](/images/80x15.png)
PII: 16706